COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,395 Articles (22,816 medRxiv, 8,579 bioRxiv)

Most recent first Previous |  Page 663: Articles 6621-6630  | Next

Effectiveness of the COVID-19 vaccines against severe disease with Omicron sub-lineages BA.4 and BA.5 in England
Kirsebom, F., Andrews, N., Stowe, J., Ramsay, M., Lopez Bernal, J.
10.1101/2022.08.31.22279444 — Posted: 2022-09-01
Periodic epidemic outbursts explained by local saturation of clusters
Gostiaux, L., Bos, W., Bertoglio, J.-P.
10.1101/2022.08.31.22279430 — Posted: 2022-09-01
Colorimetric and fluorometric reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for diagnosis of SARS-COV-2
Alhamid, G., Tombuloglu, H., Motabagani, D., Motabagani, D., Rabaan, A. A., Unver, K., Dorado, G., Al-Suhaimi, E., Unver, T.
10.1101/2022.08.30.22279408 — Posted: 2022-09-01
Heterogeneity in vaccinal immunity to SARS-CoV-2 can be addressed by a personalized booster strategy
Stoddard, M., Yuan, L., Sarkar, S., Mangalaganesh, S., Nolan, R. P., Bottino, D., Hather, G., Hochberg, N. S., White, L. F., Chakravarty, A.
10.1101/2022.08.30.22279397 — Posted: 2022-09-01
Isolating the effect of COVID-19 related disruptions on HIV diagnoses in the United States in 2020
Viguerie, A., Song, R., Satcher Johnson, A., Lyles, C. M., Hernandez, A., Farnham, P. G.
10.1101/2022.08.30.22279222 — Posted: 2022-09-01
A qualitative process evaluation using the behaviour change wheel approach: Did a whole genome sequence report form (SRF) used to reduce nosocomial SARS-CoV-2 within UK hospitals operate as anticipated?
Flowers, P., Leiser, R., Mapp, F., McLeod, J., Stirrup, O., Illingworth, C. J., Blackstone, J., Breuer, J.
10.1101/2022.08.30.22279427 — Posted: 2022-09-01
Racism and Racial Injustice During COVID-19: Impact on University Student Mental Health
Boitet, L. M., Estep, C., Schwiebert, L. M., Upshaw, K., Wolfner, C., Hutson Chatham, A., Garner, S., Stowe, A., Lanzi, R.
10.1101/2022.08.30.22279409 — Posted: 2022-09-01
Zero-COVID policy or Living-with-COVID policy? Analysis Based on Percent Excess Mortality
Cao, X., Li, Y., Zi, Y., Zhu, Y.
10.1101/2022.08.31.22279422 — Posted: 2022-09-01
Prophylactic Treatment of COVID-19 in Care Homes Trial (PROTECT-CH)
Bath, P. M., Ball, J., Boyd, M., Gage, H., Glover, M., Godfrey, M., Guthrie, B., Hewitt, J., Howard, R., Jaki, T., Juszczak, E., Lasserson, D., Leighton, P., Leyland, V., Lim, W. S., Logan, P., Meakin, G., Montgomery, A., Ogollah, R., Passmore, P., Quinlan, P., Rick, C., Royal, S., Shenkin, S. D., Upton, C., Gordon, A. L., PROTECT-CH Trialists
10.1101/2022.08.29.22279359 — Posted: 2022-08-31
The SARS-CoV-2 Spike S1 Protein Induces Global Proteomic Changes in ATII-Like Rat L2 Cells that are Attenuated by Hyaluronan
Mobley, J. A., Molyvdas, A., Kojima, K., Jilling, T., Jian-Liang, L., Garantziotis, S., Matalon, S.
10.1101/2022.08.31.506023 — Posted: 2022-08-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).